Complete Dose Comparison: Wegovy vs Mounjaro Schedules
Wegovy vs Mounjaro Equivalent Doses: Complete Treatment Phases
When comparing Wegovy and Mounjaro equivalent doses, understanding each treatment phase is essential for informed decision-making. Wegovy follows a structured 5-dose escalation: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance from week 17 onwards. Mounjaro uses a different approach with 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg doses, following its own distinct timeline. Both medications require mandatory dose escalation - you cannot skip steps regardless of which treatment you choose.
The key difference lies in their mechanisms: Wegovy contains semaglutide (GLP-1 receptor agonist only), whilst Mounjaro contains tirzepatide (dual GIP and GLP-1 receptor agonist). At EverydayMeds, we maintain complete stock levels of both treatment ranges, ensuring seamless progression through your chosen medication's dose escalation schedule without supply interruptions or the need to source alternative pharmacies mid-treatment.
Wegovy Mounjaro Equivalent Doses: Pricing and Value Comparison
Our transparent pricing structure covers every Wegovy dose: 0.25mg starter pens at £79.99, 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, and 2.4mg maintenance doses at £209.99. New customers apply code FIRST40 at checkout to access these prices, whilst returning customers use code DOSE25. Our bundle options provide treatment continuity, including the Intro Trio (0.25mg, 0.5mg, 1mg) for £299.99 and the Ultimate Stability Trio (three 2.4mg pens) for £649.99.
Mounjaro pricing follows its own structure based on the higher-strength formulations and different dosing requirements. Both treatments represent significant investments in long-term weight management, and our bundle approach ensures you can secure multiple months of supply whilst maintaining the flexibility to adjust your treatment plan with prescriber guidance. The convenience of Reliable Supply often outweighs individual pen purchasing, particularly during maintenance phases where consistent dosing is crucial.
Clinical Evidence: Wegovy vs Mounjaro Equivalent Doses Performance
In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in the STEP 1 trial (Wilding et al., NEJM, 2021). The STEP programme demonstrated consistent results across different patient populations, with STEP 2 showing clinically studied weight loss in patients with type 2 diabetes, and STEP 5 maintaining clinically studied weight loss at 2 years.
Mounjaro's clinical trials show different results due to distinct trial designs and patient populations, making direct comparison inappropriate. Both medications demonstrated cardiovascular benefits in their respective studies, with Wegovy's SELECT trial showing 20% reduction in major cardiovascular events. Your prescriber can discuss which evidence base aligns better with your individual health profile and treatment goals.
How Wegovy Works: Understanding the GLP-1 Mechanism
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to support weight management alongside a reduced-calorie diet and increased physical activity. This prescription-only medicine works by slowing gastric emptying, which helps you feel fuller for longer after smaller meals. The medication also acts on brain appetite centres, potentially reducing food cravings and the psychological drive to eat. Unlike some weight management approaches, Wegovy addresses multiple pathways involved in appetite regulation and food intake. The once-weekly FlexTouch pen delivery system maintains consistent medication levels, supporting steady appetite management throughout each dosing period. Clinical assessment is required to determine if Wegovy is suitable for your individual circumstances and health profile.
Ordering Process: Seamless Wegovy Mounjaro Equivalent Doses Access
Our streamlined ordering process begins with a 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Qualified prescribers review your application within 3 working days (or 24 hours with express service), ensuring appropriate medication selection and dosing recommendations. Once approved, your medication ships via next-day delivery using our temperature-controlled cold-chain system to maintain product integrity. Our GPhC-registered pharmacy (#9012878) status ensures regulatory compliance and professional oversight throughout the supply process. Follow-up consultations help monitor your progress and adjust treatment plans as needed, whether you're comparing Wegovy and Mounjaro equivalent doses or transitioning between dose levels within your chosen medication.
Storage and Practical Considerations: Wegovy vs Mounjaro Handling
Wegovy offers a storage advantage with its FlexTouch pens remaining stable for up to 6 weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medications require refrigerated storage at 2-8°C before first use, but Wegovy's extended room temperature stability provides greater flexibility for travel and daily use. The pre-filled pen format eliminates mixing or preparation steps, with clear dose markings ensuring accurate administration throughout the escalation schedule. Proper injection technique and site rotation help minimise injection site reactions, and our clinical team provides comprehensive guidance on handling, storage, and administration best practices. This practical advantage can influence treatment choice, particularly for patients with active lifestyles or frequent travel requirements.
Complete Dose Journey: Why Comprehensive Wegovy Mounjaro Equivalent Doses Matter
Treatment success depends on consistent progression through the complete dose escalation schedule without supply interruptions or forced medication switches. Many patients encounter supply issues mid-treatment, disrupting their progress and potentially causing side effects from dose inconsistencies. Our comprehensive stock holding across all Wegovy doses eliminates these risks, ensuring seamless progression from 0.25mg starter doses through to 2.4mg maintenance therapy.
The ability to compare Wegovy and Mounjaro equivalent doses within a single pharmacy relationship provides continuity of care and consistent clinical oversight. Your treatment history, side effect profile, and response patterns remain documented within our system, enabling more informed prescriber decisions if dose adjustments or treatment modifications become necessary. This comprehensive approach supports long-term treatment success and reduces the complexity often associated with weight management medication.
Expert Support: Making Informed Wegovy Mounjaro Equivalent Doses Decisions
Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment aligns with your individual needs, health profile, and lifestyle requirements. Our clinical team understands the nuances of each medication's dose progression, side effect profiles, and practical considerations that influence long-term adherence. Whether you're comparing initial efficacy expectations, long-term maintenance requirements, or practical factors like storage and travel considerations, professional guidance ensures informed treatment selection.
The decision between these treatments involves multiple factors beyond simple dose equivalency, including your medical history, concurrent medications, and personal preferences regarding injection frequency and dose escalation timelines. Our comprehensive approach includes ongoing monitoring, dose adjustment support, and the flexibility to modify your treatment plan as your needs evolve. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment and access expert guidance on choosing between these leading weight management treatments.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
